Arctic Therapeutics (ATx)
Arctic Therapeutics is an Icelandic drug discovery and development company focused on creating safer and more effective treatments for challenging diseases. They leverage applied genomics to develop treatments for dementia and inflammatory skin diseases, with two lead candidates, AT-001 and AT-004, currently in clinical trials.
Funding Round: Series A
Funding Amount: €26.5M
Date: 22-Jan-2025
Investors: EIC Fund, Kaldbakur, Sanos Group, Cerebrum DAO, The Lurie Family Foundation, Kerecis co-founders, Chemometec, Icelandic institutional investors and family offices
Markets: Biotechnology, Pharmaceuticals, Drug Discovery
HQ: Reykjavik, Iceland, Iceland
Founded: 2015
Website: https://www.arctictherapeutics.com/
LinkedIn: https://www.linkedin.com/company/80998499/admin/page-posts/published/
Leave a Comment
Comments
No comments yet.